Search research articles
Contact Us
Filters
Showing results (81-90 of 85) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 85 results.
Genome Medicine
|
August 23, 2023
Long-read sequencing identifies a common transposition haplotype predisposing for CLCNKB deletions
Nikolai Tschernoster, Florian Erger, Stefan Kohl, et al.
The Lancet. Primary Care
|
June 18, 2026
Chemical adherence testing-guided intervention versus standard of care in patients with hypertension who are non-adherent to antihypertensive treatment in the UK (OUTREACH): a multicentre, randomised controlled trial
Maciej Tomaszewski, Pankaj Gupta, Philip Chowienczyk, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2026
Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300)
Stephen Walsh, William O Hahn, Wilton B Williams, et al.
Nature Medicine
|
May 13, 2022
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial
Boris Julg, Kathryn E Stephenson, Kshitij Wagh, et al.
Research Square
|
May 19, 2023
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial
Angela Branche, Nadine Rouphael, David Diemert, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 85) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 85 results.
Genome Medicine
|
August 23, 2023
Long-read sequencing identifies a common transposition haplotype predisposing for CLCNKB deletions
Nikolai Tschernoster, Florian Erger, Stefan Kohl, et al.
The Lancet. Primary Care
|
June 18, 2026
Chemical adherence testing-guided intervention versus standard of care in patients with hypertension who are non-adherent to antihypertensive treatment in the UK (OUTREACH): a multicentre, randomised controlled trial
Maciej Tomaszewski, Pankaj Gupta, Philip Chowienczyk, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2026
Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300)
Stephen Walsh, William O Hahn, Wilton B Williams, et al.
Nature Medicine
|
May 13, 2022
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial
Boris Julg, Kathryn E Stephenson, Kshitij Wagh, et al.
Research Square
|
May 19, 2023
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial
Angela Branche, Nadine Rouphael, David Diemert, et al.
Page
of 9